Amphastar Pharmaceuticals, Inc.

Amphastar Pharmaceuticals, Inc. financial statements

Amphastar Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 719.89M10-K
Net incomeUSD 98.09M10-K
Cash and equivalentsUSD 170.18M10-Q
Total debtUSD 621.35M10-Q

Amphastar Pharmaceuticals, Inc. financials on 6ix · Amphastar Pharmaceuticals, Inc. on 6ix